Literature DB >> 23394112

Ligand binding site identification by higher dimension molecular dynamics.

Achani K Yatawara1, Milan Hodoscek, Dale F Mierke.   

Abstract

We propose a new molecular dynamics (MD) protocol to identify the binding site of a guest within a host. The method utilizes a four spatial (4D) dimension representation of the ligand allowing for rapid and efficient sampling within the receptor. We applied the method to two different model receptors characterized by diverse structural features of the binding site and different ligand binding affinities. The Abl kinase domain is comprised of a deep binding pocket and displays high affinity for the two chosen ligands examined here. The PDZ1 domain of PSD-95 has a shallow binding pocket that accommodates a peptide ligand involving far fewer interactions and a micromolar affinity. To ensure completely unbiased searching, the ligands were placed in the direct center of the protein receptors, away from the binding site, at the start of the 4D MD protocol. In both cases, the ligands were successfully docked into the binding site as identified in the published structures. The 4D MD protocol is able to overcome local energy barriers in locating the lowest energy binding pocket and will aid in the discovery of guest binding pockets in the absence of a priori knowledge of the site of interaction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23394112      PMCID: PMC3706581          DOI: 10.1021/ci300561b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  30 in total

1.  Global energy minimization by rotational energy embedding.

Authors:  G M Crippen; T F Havel
Journal:  J Chem Inf Comput Sci       Date:  1990-08

2.  An approach to the multiple-minima problem in protein folding by relaxing dimensionality. Tests on enkephalin.

Authors:  E O Purisima; H A Scheraga
Journal:  J Mol Biol       Date:  1987-08-05       Impact factor: 5.469

3.  Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95.

Authors:  H C Kornau; L T Schenker; M B Kennedy; P H Seeburg
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

4.  Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases.

Authors:  E Kim; M Niethammer; A Rothschild; Y N Jan; M Sheng
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

5.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.

Authors:  P J Welch; J Y Wang
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

6.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

7.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.

Authors:  T Schindler; W Bornmann; P Pellicena; W T Miller; B Clarkson; J Kuriyan
Journal:  Science       Date:  2000-09-15       Impact factor: 47.728

8.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.

Authors:  M J Eck; S E Shoelson; S C Harrison
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

9.  A structure refinement method based on molecular dynamics in four spatial dimensions.

Authors:  R C van Schaik; H J Berendsen; A E Torda; W F van Gunsteren
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

10.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).

Authors:  Bhushan Nagar; William G Bornmann; Patricia Pellicena; Thomas Schindler; Darren R Veach; W Todd Miller; Bayard Clarkson; John Kuriyan
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.